key: cord-0777366-2rjeevc1
authors: Uribarri, Jaime; El Shamy, Osama; Sharma, Shuchita; Winston, Jonathan
title: COVID-19–Associated Acute Kidney Injury and Quantified Protein Catabolic Rate: A Likely Effect of Cytokine Storm on Muscle Protein Breakdown
date: 2020-12-01
journal: Kidney Med
DOI: 10.1016/j.xkme.2020.09.011
sha: f68eb68c857da5e1a2dd736a2e49ee1d36913770
doc_id: 777366
cord_uid: 2rjeevc1

RATIONALE & OBJECTIVES: Previously we reported a cohort of COVID19-associated acute kidney injury (AKI) patients with striking biochemical evidence of tissue breakdown in the absence of apparent rhabdomyolysis. Herein we sought to quantify the extent of tissue catabolism in similar patients. STUDY DESIGN: During acute peritoneal dialysis (PD) in COVID-AKI patients we measured urea Kt/V adequacy and calculated daily urea nitrogen generation rate while quantifying their daily protein intake. SETTING AND POPULATION: We did calculations in 8 COVID-AKI patients undergoing acute PD at the Mount Sinai Hospital in NYC. As a comparator we obtained urea kinetic parameters from our database of ambulatory patients on maintenance PD. EXPOSURE OR PREDICTORS: 8 COVID-AKI patients undergoing acute PD. OUTCOMES: Urea nitrogen generation rate in relation to daily protein intake ANALYTICAL APPROACH: Urea nitrogen generation rate from urea kinetics was related to measured daily dietary protein intake in these patients and compared it to this relationship in ambulatory maintenance PD patients where both parameters were calculated from urea kinetics. RESULTS: Urea nitrogen generation rate in AKI patients was 10.2 + 5g/day, which is >2 fold higher than stable outpatients on maintenance PD (4.7 + 3g/day), despite similar dietary protein intake (74.8 + 11g/day vs 67.2 + 29g/day, respectively). This strongly suggests endogenous protein breakdown, probably from muscle. Urea nitrogen generation rate in these AKI patients corresponds to 315g/day of ongoing muscle breakdown and cumulative 2.5kg muscle breakdown during the early course of AKI. LIMITATIONS: Small number of participants as well as assumptions in comparing Urea nitrogen generation rate with protein intake CONCLUSIONS: In highly catabolic patients, an endogenous source of urea generation, such as muscle protein breakdown, seems to be the most likely explainable cause for our findings. This is the first study that we are aware of to quantify the degree of endogenous protein breakdown induced by COVID cytokine storm.

During the peak of the COVID-19 pandemic in the greater New York area, acute kidney injury (AKI) was identified as a major complication of the disease. 1 We have previously reported on a subset of AKI patients, a high number of critically ill patients in the ICU with striking biochemical evidence of tissue breakdown, 2 a metabolic state typically characteristic of tumor lysis syndrome or rhabdomyolysis. 3, 4 All patients had COVID-19 pneumonia with respiratory failure and AKI, but none had cancer or high CPK levels. 2 We postulated that the catabolic state was part of the COVID-19 cytokine storm. 2 In view of the increasing number of patients requiring dialysis for both acute and chronic kidney disease, 5 many nephrologists were faced with obstacles to meeting dialysis demands, including staffing and supply shortages, as well as dialysis circuit thrombosis. Acute peritoneal dialysis became a valuable alternative for dialyzing AKI patients and we have previously described the implementation of an acute PD program in our institution. 6 We report here on our assessment of dialysis adequacy in some of our acute PD patients. By simultaneously estimating urea generation rate, we demonstrate a striking degree of protein breakdown, most likely of muscle origin, in these critically ill, coronavirus infected patients supporting our clinical impression of a highly catabolic state. We believe this is the first such report to quantify the extent of muscle breakdown in a COVID-19 cytokine storm.

Dialysis adequacy by urea Kt/V was measured whenever feasible in all COVID-19 AKI patients who received acute PD while inpatients at Mount Sinai Hospital in NYC during the month of April 2020. 6 We report here on all 8 of these patients in whom we were able to demonstrate stability of both serum creatinine and serum urea nitrogen (SUN) levels for at least 2 days prior to urine and PD effluent sample collections. Urea and creatinine kinetics were assessed simultaneously as part of the Kt/V estimation (Adequest software, Baxter, Inc.).

All these patients developed AKI in the setting of COVID pneumonia and experienced marked increased in serum creatinine, SUN, and phosphate levels, at a rate faster than usual for AKI. Anion gap metabolic acidosis with normal levels of lactate and rapid falls in serum albumin were also seen. Together, these biochemical parameters were consistent with a hypercatabolic state, similar to what we have previously described in a different contemporaneous cohort of patients. 2 Urea nitrogen and creatinine concentrations were measured in 24-hour urine and PD effluent samples obtained during the patients' admission by the hospital clinical laboratory. 6 The following calculations were then made: The same equations were used to calculate total creatinine generation in g/day but replacing urea nitrogen with creatinine concentration.

Total body water (TBW) was then estimated depending on the patient's gender:

Men: TBW = actual body weight (kg) X 0.6 Women: TBW = actual body weight (kg) X 0.5

Weekly urea kt/V = [24 hr urinary + dialysate urea clearance (in L/day] X 7 TBW To contextualize and compare the resultant urea and creatinine kinetics, we reviewed the database of maintenance PD patients from our outpatient home dialysis unit.

From a total of 80 maintenance PD patients we matched 8 control patients for age, gender and weight (see Table 2 ).

Protein intake in g/day for the acute PD cohort was calculated directly from the dietary information of the enteral feeding solutions and /or supplemented by oral food protein content reported in the nutritionists' notes in the patients' electronic medical records. For the control group, protein intake was estimated as is standard practice, from the urea nitrogen generation rate based on the Randall formula.

Baxter's Adequest software was used for estimating dialysis adequacy (Kt/V) and urea nitrogen and creatinine generation rates. 6 All statistical analyses were performed using the SPSS 26.0 software. We used the Kolmorogov-Smirnov test to define normal distribution. All values were expressed as means + standard deviation, except for CPK. Statistical significance between the means was established using the unpaired student T test or one-way repeated measures ANOVA J o u r n a l P r e -p r o o f depending on the number of groups. P values < 0.05 were considered statistically significant.

This study was approved by the IRB at the Icahn School of Medicine at Mount Sinai; the need for informed consent was waived because of de-identified information.

Of the 8 acute PD patients, 50% were male, mean age was 59 + 10 years, weight 94.4 + 26 kg and BMI 33 + 7.7 kg/m 2 . Table 1 shows the laboratory data in these patients 

Serum creatinine and SUN levels were stable in the 2 days prior to urine and PD effluent collections. The SUN was 99 + 33.6 mg/dL on day 1, 100.2 + 31.3 mg/dL on day 2 and 100.4 + 33 mg/dL on the day of collection (p value 0.8926). Similarly, serum creatinine values were 6.3 + 5 mg/dL on day 1, 6.5 + 5 mg/dL on day 2 and 6.4 + 5 mg/dL on the day of collection (P value 0.85).

The matched maintenance PD counterparts were 50% male, mean age 58 years, weight 92.5 kg and BMI of 33.4 kg/m 2 ( Table 2) . The mean SUN level in the ESRD group was half that of the study group (55.2 vs 100.4 mg/dL).

Estimated daily protein intake was not different (74.8 vs 67.2 g/day, respectively) as was dialysis dose (weekly Kt/V 1.7 vs 2.1, respectively). The urea nitrogen generation rate in AKI patients was more than double the maintenance group (10.2 vs 4.7 g/day, respectively). The urea generation rate in controls (the maintenance PD patients) was not different than values in our entire outpatient PD cohort (n=80) (4.7 + 3 g/day vs 5.2 + 2.5 g/day, respectively).

In this study, we sought to quantify our clinical observation that some COVID-19 patients with AKI have marked tissue breakdown as is suggested clinically by rapid rises in SUN, creatinine, uric acid and phosphorus levels. 2 By leveraging the clinical information obtained when assessing peritoneal dialysis adequacy 6 , we proved this by demonstrating a much higher rate of urea nitrogen generation than can be explained by daily dietary protein intake. This becomes especially clear when these patients are compared to a cohort of age-, gender-and weight-matched ESRD patients on maintenance PD. This excessive urea nitrogen generation indicates an endogenous source that most likely comes from muscle protein breakdown. We are not aware of any other study that has quantitated the extent of tissue breakdown in this hypercatabolic state.

The urea kinetics calculations for the maintenance PD cohort, based on the Adequest program, suggest that daily urea nitrogen generation is only 7% of the daily protein intake; which fits other balance studies in maintenance PD showing that the daily urea nitrogen generation is about 8% of a daily protein intake of about 75 g. 7 If we extrapolate this data, the excess urea nitrogen generation of about 5 g/day in our acute J o u r n a l P r e -p r o o f patients would have required an endogenous protein breakdown of about 63 g/day (assuming that 8% of protein is converted into urea nitrogen). Since about 20% of muscle is protein this would translate into the loss of about 315 g of muscle each day, an impressive amount. This is on top of the initial amount of protein breakdown required to raise the SUN from normal (~20 mg/dL) to 100.4 mg/dL. This difference in SUN of 80.4 mg/dL over an average total body water of our cohort of 50 L would have required the addition of about 40 g of urea nitrogen, derived from 500 g of protein or 2.5 kg of muscle mass. This extremely large amount of protein breakdown not only confirms the hypercatabolic clinical presentation in these patients, but also may very well be contributing to morbidity and mortality.

We have previously postulated that this hypercatabolic state is another manifestation of the cytokine storm syndrome, 2 well described in COVID-associated pulmonary complications. 8, 9 Both IL-6 and TNFα have a direct effect on muscle protein breakdown and there is a growing body of literature supporting their role in muscle wasting associated with chronic inflammation, HIV, and cancer. [10] [11] [12] [13] This likely contributes to the laboratory abnormalities observed in our patients that have traditionally been described as catabolic. These abnormalities are classically found in rhabdomyolysis and tumor lysis syndrome, 3,4 neither of which was present in our previously described cohort of patients with COVID-associated AKI. 2 This study has several limitations. The most important may be that urine and PD fluid collections were not done under optimal conditions in a metabolic unit. Our participants were critically ill patients in a hospital, crowded with a tremendous influx of COVID-19 patients. We assured stability of SUN and serum creatinine for two days prior J o u r n a l P r e -p r o o f to fluid collections, but it may be argued that a longer period of stabilization might have been necessary to estimate the rate of urea nitrogen generation. There was simply no opportunity to optimize the conditions of the patients and wait until a well-demonstrated steady state had been reached. Another limitation may be that the assumption of a rate of urea nitrogen generation of 8% of the source protein is based on data from maintenance dialysis patients and may not apply in this acute condition. We would argue that even if the actual numbers are not exactly right, they undoubtedly document a significant magnitude of protein catabolism. A third limitation may be that the hypercatabolic state may not be exclusively COVID-induced, but associated with treatments associated with acute respiratory failure. One of our patients did receive an average daily dose of intravenous methylprednisolone of 40mg/d for a few days. This only partially explains the aforementioned hypercatabolism in that particular individual, but steroids cannot be the explanation in the remainder of the cohort. We cannot entirely eliminate contribution from other agents, such as investigational drugs like Remdesivir, but any study agents in this critically ill patient group were individualized, and not representative of the group.

We believe that our study provides insight into the hypercatabolic state of patients diagnosed with COVID-associated pneumonia and hopefully presents a roadmap for future further investigations and tailoring of our treatment approaches in these patients. These were values obtained before initiation of any form of dialysis in these patients. It took an average of 6 days from initial rise of serum creatinine to initiation of dialysis.

Conversion factors for units: serum urea nitrogen in mg/dL to mmol/L, x 0.357; creatinine in mg/dL to µmol/L, x88.4; calcium in mg/dL to mmol/L, x 0.2495; phosphorus in mg/dL to mmol/L, x 0.3229. 

Acute Kidney Injury in hospitalized patients with COVID-19

COVID-19 associated acute kidney injury: a case series

Onco-nephrology: tumor lysis syndrome

Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review

Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients

Acute start peritoneal dialysis during the COVID-19 pandemic: outcomes and experiences

Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis

COVID-19: consider cytokine storm syndromes and immunosuppression

SARS-CoV2: A storm is raging

Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1

Interleukin-6 induces skeletal muscle protein breakdown in rats

TNF-α and cancer cachexia: Molecular insights and clinical implications

Cytokine signaling in skeletal muscle wasting